Syneos Health is an integrated biopharmaceutical solutions company that combines clinical development, medical expertise and commercial capabilities in order to help clients accelerate the development and delivery of therapies to market. Its Biopharmaceutical Acceleration Model involves collaborative working across its operations, and using its systems and the latest technology to facilitate the delivery of biopharmaceutical products worldwide. The company has expertise in therapeutic areas such as cardiovascular, CNS, endocrine and metabolic diseases, and oncology and hematology, among other areas. It also has teams engaged in producing cross-functional solutions in areas like cell and gene therapy. Syneos Health is publicly held.
No investor data is available
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.